177 related articles for article (PubMed ID: 31687646)
1. Use of Denosumab in Children With Osteoclast Bone Dysplasias: Report of Three Cases.
Upfill-Brown A; Bukata S; Bernthal NM; Felsenfeld AL; Nelson SD; Singh A; Wesseling-Perry K; Eilber FC; Federman NC
JBMR Plus; 2019 Oct; 3(10):e10210. PubMed ID: 31687646
[TBL] [Abstract][Full Text] [Related]
2. Denosumab in pediatric bone disorders and the role of RANKL blockade: a narrative review.
Wang D; Tang X; Shi Q; Wang R; Ji T; Tang X; Guo W
Transl Pediatr; 2023 Mar; 12(3):470-486. PubMed ID: 37035391
[TBL] [Abstract][Full Text] [Related]
3. Clinical and Radiologic Response of Central Giant Cell Granuloma to Denosumab: A 6-Year Prospective Observational Study.
Rhou YJJ; Wang CJ; Nguyen M; Vanderniet JA; Munns CF; Coleman H; Kim J; Holmes-Walker DJ; Lim L; Girgis CM
Calcif Tissue Int; 2022 Apr; 110(4):464-474. PubMed ID: 35088118
[TBL] [Abstract][Full Text] [Related]
4. Denosumab for central giant cell granuloma in an Australian tertiary paediatric centre.
Vanderniet JA; Wall CL; Mullins A; London K; Lim L; Hibbert S; Briody J; Padhye B; Poon M; Biggin A; Dalla-Pozza L; Munns CF
Bone; 2022 Jun; 159():116395. PubMed ID: 35331976
[TBL] [Abstract][Full Text] [Related]
5. Denosumab-Induced Rebound Hypercalcemia Treated With Bisphosphonates in a Pediatric Patient.
Gandolfi A; Shaaban S
JCEM Case Rep; 2023 Sep; 1(5):luad133. PubMed ID: 37908209
[TBL] [Abstract][Full Text] [Related]
6. Local Tumor Recurrence and Escape from Suppression of Bone Resorption With Denosumab Treatment in Two Adolescents With Giant Cell Tumors of Bone.
Akel U; Robinson ME; Werier J; Rampersaud R; Rakhra K; Johnston D; Konji VN; Ma J; Pagé M; Matzinger MA; Ward LM
JBMR Plus; 2019 Sep; 3(9):e10196. PubMed ID: 31667453
[TBL] [Abstract][Full Text] [Related]
7. Management of central giant cell granuloma with subcutaneous denosumab therapy.
Naidu A; Malmquist MP; Denham CA; Schow SR
J Oral Maxillofac Surg; 2014 Dec; 72(12):2469-84. PubMed ID: 25262402
[TBL] [Abstract][Full Text] [Related]
8. Failure of Oral Risedronate Therapy to Prevent Spontaneous Vertebral Fracture in a Patient Ceasing Denosumab: A Cautionary Case.
Davidoff DF; Girgis CM
JBMR Plus; 2020 Oct; 4(10):e10396. PubMed ID: 33103026
[TBL] [Abstract][Full Text] [Related]
9. Osteonecrosis of the Jaw and Rebound Hypercalcemia in Young People Treated With Denosumab for Giant Cell Tumor of Bone.
Uday S; Gaston CL; Rogers L; Parry M; Joffe J; Pearson J; Sutton D; Grimer R; Högler W
J Clin Endocrinol Metab; 2018 Feb; 103(2):596-603. PubMed ID: 29211870
[TBL] [Abstract][Full Text] [Related]
10. Aneurysmal bone cyst: results of an off label treatment with Denosumab.
Dürr HR; Grahneis F; Baur-Melnyk A; Knösel T; Birkenmaier C; Jansson V; Klein A
BMC Musculoskelet Disord; 2019 Oct; 20(1):456. PubMed ID: 31630689
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and safety of denosumab treatment in a prepubertal patient with cherubism.
Kawamura H; Watanabe S; I T; Asahina I; Moriuchi H; Dateki S
J Pediatr Endocrinol Metab; 2020 Jul; 33(7):963-966. PubMed ID: 32649295
[TBL] [Abstract][Full Text] [Related]
12. Successful denosumab treatment for central giant cell granuloma in a 9-year-old child.
Mariz BALA; Migliorati CA; Alves FA; Penteado FM; Carvalho NP; Santos-Silva AR; Rocha AC
Spec Care Dentist; 2021 Jul; 41(4):519-525. PubMed ID: 33760257
[TBL] [Abstract][Full Text] [Related]
13. Response of Aneurysmal Bone Cyst to Denosumab.
Skubitz KM; Peltola JC; Santos ER; Cheng EY
Spine (Phila Pa 1976); 2015 Nov; 40(22):E1201-4. PubMed ID: 26730528
[TBL] [Abstract][Full Text] [Related]
14. Critical hypercalcemia following discontinuation of denosumab therapy for metastatic giant cell tumor of bone.
Gossai N; Hilgers MV; Polgreen LE; Greengard EG
Pediatr Blood Cancer; 2015 Jun; 62(6):1078-80. PubMed ID: 25556556
[TBL] [Abstract][Full Text] [Related]
15. Denosumab Treatment Does Not Halt Progression of Bone Lesions in Multicentric Carpotarsal Osteolysis Syndrome.
Lerman MA; Francavilla M; Waqar-Cowles L; Levine MA
JBMR Plus; 2023 May; 7(5):e10729. PubMed ID: 37197321
[TBL] [Abstract][Full Text] [Related]
16. The Efficacy of Denosumab in the Management of a Tibial Paediatric Aneurysmal Bone Cyst Compromised by Rebound Hypercalcaemia.
Harcus M; Aldridge S; Abudu A; Jeys L; Senniappan S; Morgan H; Pizer B
Case Rep Pediatr; 2020; 2020():8854441. PubMed ID: 33376615
[TBL] [Abstract][Full Text] [Related]
17. Surgical Management and Denosumab for Aneurysmal Bone Cysts of the Spine in an Australian Tertiary Paediatric Centre.
Vanderniet JA; Tsinas D; Wall CL; Girgis CM; London K; Keane C; Briody J; Hibbert S; Poon M; Padhye B; Biggin A; Dalla-Pozza L; Gray RJ; Munns CF
Calcif Tissue Int; 2023 May; 112(5):592-602. PubMed ID: 36810677
[TBL] [Abstract][Full Text] [Related]
18. Hypercalcaemia after treatment with denosumab in children: bisphosphonates as an option for therapy and prevention?
Sydlik C; Dürr HR; Pozza SB; Weißenbacher C; Roeb J; Schmidt H
World J Pediatr; 2020 Oct; 16(5):520-527. PubMed ID: 32776272
[TBL] [Abstract][Full Text] [Related]
19. Improvement of Giant Cell Lesions of the Jaw Treated With High and Low Doses of Denosumab: A Case Series.
Kim TS; Usera GL; Ruggiero SL; Weinerman SA
JBMR Plus; 2017 Oct; 1(2):101-106. PubMed ID: 30283883
[TBL] [Abstract][Full Text] [Related]
20. Denosumab for treating aneurysmal bone cysts in children.
Raux S; Bouhamama A; Gaspar N; Brugières L; Entz-Werlé N; Mallet C; Dijoud F; Gouin F; Marec-Bérard P
Orthop Traumatol Surg Res; 2019 Oct; 105(6):1181-1185. PubMed ID: 31358461
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
